Contact Us | Current Operating Status
Office of News and Public Information
Back | Home
November 18, 2005

Running Time: 00:55:30
Format: RealAudio (Requires free RealPlayer)

Intellectual property restrictions rarely impose burdens on genomic and proteomic research, but there are reasons to be apprehensive about their future impact on advances in this field, says a new report from the National Research Council. Policy-makers should take steps to prevent the increasingly complex web of intellectual property protections from getting in the way of potential biomedical breakthroughs.

Shirley Tilghman, president, Princeton University, Princeton, N.J. and Roderick McKelvie, partner, Covington & Burling, Washington, D.C.